Compare ARDX & EIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ARDX | EIG |
|---|---|---|
| Founded | 2007 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 797.8M | 928.6M |
| IPO Year | 2014 | 2006 |
| Metric | ARDX | EIG |
|---|---|---|
| Price | $3.02 | $46.39 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 3 |
| Target Price | $12.80 | ★ $54.00 |
| AVG Volume (30 Days) | ★ 4.3M | 117.0K |
| Earning Date | 11-03-2026 | 10-28-2026 |
| Dividend Yield | N/A | ★ 3.04% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.73 |
| Revenue | $2,607,000.00 | ★ $858,700,000.00 |
| Revenue This Year | $19.21 | N/A |
| Revenue Next Year | $28.19 | N/A |
| P/E Ratio | ★ N/A | $21.92 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.96 | $36.00 |
| 52 Week High | $8.40 | $53.51 |
| Indicator | ARDX | EIG |
|---|---|---|
| Relative Strength Index (RSI) | 37.18 | 33.36 |
| Support Level | N/A | $41.68 |
| Resistance Level | $3.35 | $46.72 |
| Average True Range (ATR) | 0.13 | 1.69 |
| MACD | 0.01 | -0.61 |
| Stochastic Oscillator | 15.19 | 21.09 |
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
Employers Holdings Inc is a provider of workers' compensation insurance and services focused on small and mid-sized businesses engaged in low-to-medium hazard industries. Its customers are employers, and the insurance premiums that those employers pay to account for company revenue. Substantially all of the remaining revenue is generated through investments. The company operates exclusively in the United States, and it generates more than half of its business in California. By industry, the company has exposure to restaurants, which account for roughly a fourth of the total premiums the company earns. It operates as a single reportable segment, Insurance Operations through its wholly owned subsidiaries.